tirzepatide / cyanocobalamin Troubling Findings in Study of GLP-1 Compounders Compounded Tirzepatide+B12 - Team Wellcore

A fund from Mitsubishi Tanabe Pharma Corporation was partly used for recruitment of 12 healthy controls

doi: 10.3389/fsurg.2022.973883 Received 20 June 2022 Accepted 12 August 2022 Published 31 August 2022 Volume 9 - 2022 Edited by Pasquale Cianci, Azienda Sanitaria Localedella Provincia di Barletta Andri Trani (ASL BT), Italy Reviewed by Abdullah Ozgur Yeniova, Tokat Gaziosmanpaa University, Turkey Marina Minafra, Ospedale civile "Lorenzo Bonomo", Italy Updates Copyright 2022 Zhao, Chen, Xing, Yu and Liu

24 , 18901901 e1898 (2018)

123 "Michael Greger, M.D." HuffPost

The most common dose for treating deficiency is 1,000 mcg